B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.
about
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@en
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@nl
type
label
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@en
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@nl
prefLabel
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@en
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@nl
P2093
P2860
P356
P1476
B cell-based therapies in CNS ...... d CD20 as therapeutic targets.
@en
P2093
Daniel M Cimbora
Eliezer Katz
John Nolan Ratchford
Thomas G Forsthuber
P2860
P304
1756286418761697
P356
10.1177/1756286418761697
P50
P577
2018-03-21T00:00:00Z